Profit Expected to Dip for Teva Pharmaceutical Industries – Forbes

Profit Expected to Dip for Teva Pharmaceutical Industries
Forbes
Despite an expected dip in profit, analysts are generally optimistic about Teva Pharmaceutical Industries as it prepares to reports its third-quarter earnings on Thursday, October 30, 2014. The consensus earnings per share estimate is $1.23 per share.
Teva Pharmaceutical Industries Ltd Given Neutral Rating at Zacks (TEVA)Mideast Time

all 2 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd